Plain-English translation of NCT07186101 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Ulcerative Colitis research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether adding a new medication called to an existing treatment called helps people with moderate to severe ulcerative colitis feel better. Half of the participants will receive both medications together, while the other half will receive alone. The study will compare how well the combination works compared to the existing treatment by itself.
Even with current treatments, many people with ulcerative colitis still struggle with severe symptoms and flare-ups. Researchers believe that combining this new oral medication with an existing treatment might work better than either treatment alone, giving patients more relief.
You likely qualify if…
You likely don't qualify if…
You will take part in the study for approximately 2 years, with about 21 visits to the clinic. You'll take an oral medication daily and receive the injectable treatment through an IV initially, then as an injection under your skin. During the study, your doctor will monitor how well the treatment works and check for any side effects through regular visits and tests. If the treatment works well for you after the initial period, you may continue in a second phase of the study.
AI-generated summary from trial data · Sep 16, 2026 · Not medical advice
United States